Show simple item record

dc.contributor.authorVinayak, B
dc.contributor.authorLiu, L
dc.contributor.authorEspirritu, S
dc.contributor.authorLalonde, E
dc.contributor.authorYamaguchi, T
dc.contributor.authorHeisler, L
dc.contributor.authorLivingstone, J
dc.contributor.authorHuang, V
dc.contributor.authorShiah, YJ
dc.contributor.authorSabelnykova, V
dc.contributor.authorYousif, F
dc.contributor.authorFraser, M
dc.contributor.authorChua, M
dc.contributor.authorvan der Kwast, T
dc.contributor.authorLiu, SK
dc.contributor.authorBoutros, PC
dc.contributor.authorBristow, Robert G
dc.date.accessioned2019-11-19T16:01:13Z
dc.date.available2019-11-19T16:01:13Z
dc.date.issued2019en
dc.identifier.citationVinayak B, Liu L, Espirritu S, Lalonde E, Yamaguchi T, Heisler L, et al. The molecular hallmarks and clinical consequences of tumor hypoxia in prostate cancer. J Clin Oncol. 2019;37(7_suppl):81-.en
dc.identifier.doi10.1200/JCO.2019.37.7_suppl.81en
dc.identifier.urihttp://hdl.handle.net/10541/622508
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2019.37.7_suppl.81en
dc.titleThe molecular hallmarks and clinical consequences of tumor hypoxia in prostate canceren
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Toronto, Toronto, ON, Canadaen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record